In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
BioPharmaceutical Medical Device

In Vivo Needs Your Feedback!

  • Opinion
  • Nancy Dvorin
    Nancy Dvorin

Executive Summary

Please take our brief reader survey to help In Vivo evolve to meet your needs in 2018. No strings attached, and those who complete the survey will be in the running for Amazon gift vouchers.

January marks the launch of Informa's “Pharma Feedback” program, an effort to reach out to you – our customers – to get a better understanding of your challenges and needs so that our plans for 2018 reflect the right improvements to our content and its delivery.

We hope you will be candid about your opinions as we fine-tune In Vivo and the rest of Informa Pharma Intelligence's best-in-the-business publications.

Please tell us what you think by CLICKING HERE to take our brief survey.

Everyone who completes the survey is eligible to enter a drawing to win one of four Amazon gift vouchers valued at $100.

Thanks in advance for your participation.

Table

View full table

Topics

Tags:
BioPharmaceutical Medical Device
Latest Headlines

As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure

South Korea Sees Pharma Leadership Transition

FDA-EMA Advice Pilot For Complex Generics: What Does Industry Have To Say?

The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’

See All
UsernamePublicRestriction

Register

IV005257

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By